Literature DB >> 19343139

Resectability of initially unresectable liver metastases from colorectal cancer should not be the primary end point of clinical trials.

Alberto Sobrero1, Giuseppe Aprile.   

Abstract

Entities:  

Year:  2009        PMID： 19343139      PMCID： PMC2661123     

Source DB:  PubMed          Journal:  Gastrointest Cancer Res        ISSN： 1934-7820


× No keyword cloud information.
  9 in total

1.  Perioperative or adjuvant therapy for resectable colorectal hepatic metastases.

Authors:  Nicholas J Petrelli
Journal:  J Clin Oncol       Date:  2008-09-15       Impact factor: 44.544

2.  Neoadjuvant treatment of unresectable colorectal liver metastases: correlation between tumour response and resection rates.

Authors:  G Folprecht; A Grothey; S Alberts; H-R Raab; C-H Köhne
Journal:  Ann Oncol       Date:  2005-05-03       Impact factor: 32.976

3.  Oxaliplatin, fluorouracil, and leucovorin for patients with unresectable liver-only metastases from colorectal cancer: a North Central Cancer Treatment Group phase II study.

Authors:  Steven R Alberts; William L Horvath; William C Sternfeld; Richard M Goldberg; Michelle R Mahoney; Shaker R Dakhil; Ralph Levitt; Kendrith Rowland; Suresh Nair; Daniel J Sargent; John H Donohue
Journal:  J Clin Oncol       Date:  2005-10-17       Impact factor: 44.544

Review 4.  Surgical strategies for colorectal liver metastases.

Authors:  Graeme J Poston
Journal:  Surg Oncol       Date:  2004 Aug-Nov       Impact factor: 3.279

5.  Rescue surgery for unresectable colorectal liver metastases downstaged by chemotherapy: a model to predict long-term survival.

Authors:  René Adam; Valérie Delvart; Gérard Pascal; Adrian Valeanu; Denis Castaing; Daniel Azoulay; Sylvie Giacchetti; Bernard Paule; Francis Kunstlinger; Odile Ghémard; Francis Levi; Henri Bismuth
Journal:  Ann Surg       Date:  2004-10       Impact factor: 12.969

6.  Urgent need for a new staging system in advanced colorectal cancer.

Authors:  Graeme J Poston; Joan Figueras; Felice Giuliante; Gennaro Nuzzo; Alberto F Sobrero; Jean-Francois Gigot; Bernard Nordlinger; Rene Adam; Thomas Gruenberger; Michael A Choti; Anton J Bilchik; Eric J D Van Cutsem; Jy-Ming Chiang; Michael I D'Angelica
Journal:  J Clin Oncol       Date:  2008-08-18       Impact factor: 44.544

7.  Combination of surgery and chemotherapy and the role of targeted agents in the treatment of patients with colorectal liver metastases: recommendations from an expert panel.

Authors:  B Nordlinger; E Van Cutsem; T Gruenberger; B Glimelius; G Poston; P Rougier; A Sobrero; M Ychou
Journal:  Ann Oncol       Date:  2009-01-19       Impact factor: 32.976

8.  Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.

Authors:  Hanna K Sanoff; Daniel J Sargent; Megan E Campbell; Roscoe F Morton; Charles S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Journal:  J Clin Oncol       Date:  2008-11-10       Impact factor: 44.544

9.  Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial.

Authors:  Bernard Nordlinger; Halfdan Sorbye; Bengt Glimelius; Graeme J Poston; Peter M Schlag; Philippe Rougier; Wolf O Bechstein; John N Primrose; Euan T Walpole; Meg Finch-Jones; Daniel Jaeck; Darius Mirza; Rowan W Parks; Laurence Collette; Michel Praet; Ullrich Bethe; Eric Van Cutsem; Werner Scheithauer; Thomas Gruenberger
Journal:  Lancet       Date:  2008-03-22       Impact factor: 79.321
  9 in total
  1 in total

Review 1.  The role of vitamin D in hepatic metastases from colorectal cancer.

Authors:  E Shaw; N Massaro; N T Brockton
Journal:  Clin Transl Oncol       Date:  2017-08-11       Impact factor: 3.405
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.